Rowland Carmichael Advisors’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
– Sell
-4,086
Closed -$203K – 357
2019
Q2
$203K Sell
4,086
-919
-18% -$43.2K 0.07% 257
2019
Q1
$213K Hold
5,005
– – 0.08% 245
2018
Q4
$206K Sell
5,005
-542
-10% -$23.3K 0.09% 218
2018
Q3
$259K Buy
5,547
+74
+1% +$3.38K 0.1% 223
2018
Q2
$239K Buy
+5,473
New +$255K 0.1% 240

Other funds holding MET

Rowland Carmichael Advisors's MET Position: Q3 2019 in Review

Rowland Carmichael Advisors sold out of MetLife (MET) in Q3 2019, closing a stake of 4,086 shares — an estimated $203K sold.

Rowland Carmichael Advisors first reported a position in MET in Q2 2018 and held it in 5 quarters. The position peaked at $259K in Q3 2018. 1,043 funds tracked by Wall St. Rank hold MET as of Q3 2019.

  • Rowland Carmichael Advisors reported no remaining MetLife position as of Q3 2019 after selling out during the quarter.
  • Rowland Carmichael Advisors sold 4,086 MetLife shares in Q3 2019, an estimated $203K.
  • Rowland Carmichael Advisors first reported a position in MetLife in Q2 2018 and held it in 5 quarters.
  • Rowland Carmichael Advisors's MetLife position peaked at $259K in Q3 2018.
  • 1,043 funds tracked by Wall St. Rank held MetLife as of Q3 2019.

Based on Rowland Carmichael Advisors's 13F filing for Q3 2019, filed 10 Feb 2020.